Next, after treating GBM cells whose EN2 was overexpressed with cinobufotalin or NDI‐091143, we found that these treatments effectively suppressed the enhanced proliferation and invasion capacity of GBM cells induced by EN2 overexpression. The gene discussed is EN2; the disease is glioblastoma.